Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Subscribe To Our Newsletter & Stay Updated
